ProAssurance Corp.

  • Market Cap: Small Cap
  • Industry: Insurance
  • ISIN: US74267C1062
USD
23.86
-0.07 (-0.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About ProAssurance Corp. stock-summary
stock-summary
ProAssurance Corp.
Insurance
ProAssurance Corporation (ProAssurance) is a holding company for property and casualty insurance companies. The Company provides professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, liability insurance for medical technology and life sciences risks, and workers' compensation insurance. The Company operates through four segments. The Specialty property and casualty segment includes the Company's professional liability business, and medical technology and life sciences business. The Workers' compensation segment includes its workers' compensation business. Lloyd's Syndicate 1729 (Syndicate 1729) segment includes business of Syndicate 1729, which underwrites risks over a range of property and casualty insurance and reinsurance lines. The Corporate segment includes the Company's investment operations managed at the corporate level and non-premium revenues generated outside of its insurance entities.
Company Coordinates stock-summary
Company Details
100 Brookwood Pl , BIRMINGHAM AL : 35209-6811
stock-summary
Tel: 1 205 87744001 205 8774461
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 58 Schemes (50.16%)

Foreign Institutions

Held by 84 Foreign Institutions (10.92%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. William Starnes
Executive Chairman of the Board
Mr. Thomas Wilson
Lead Independent Director
Mr. Kedrick Adkins
Independent Director
Mr. Bruce Angiolillo
Independent Director
Mr. Samuel Di Piazza
Independent Director
Dr. Robert Flowers
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
22 Million
stock-summary
Industry

Insurance

stock-summary
Market cap

USD 1,444 Million (Small Cap)

stock-summary
P/E

33.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

3.82%

stock-summary
Price to Book

1.13